10.62 USD
-0.11 (-1.03%)
Last: Feb 2, 2026, 01:41 PM
Taking everything into account, FULC scores 4 out of 10 in our fundamental rating. FULC was compared to 191 industry peers in the Pharmaceuticals industry. No worries on liquidiy or solvency for FULC as it has an excellent financial health rating, but there are worries on the profitability. FULC is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year FULC has reported negative net income.
- FULC had a negative operating cash flow in the past year.
- In the past 5 years FULC always reported negative net income.
- FULC had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of -4.53%, FULC is in the better half of the industry, outperforming 72.25% of the companies in the same industry.
- FULC's Return On Equity of -4.90% is fine compared to the rest of the industry. FULC outperforms 76.96% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.53% | ||
| ROE | -4.9% | ||
| ROIC | N/A |
ROA(3y)-29.99%
ROA(5y)-35.8%
ROE(3y)-33.54%
ROE(5y)-42.65%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- FULC does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- FULC does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, FULC has less shares outstanding
- FULC has more shares outstanding than it did 5 years ago.
- There is no outstanding debt for FULC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- An Altman-Z score of 18.54 indicates that FULC is not in any danger for bankruptcy at the moment.
- FULC's Altman-Z score of 18.54 is amongst the best of the industry. FULC outperforms 86.91% of its industry peers.
- FULC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 18.54 |
ROIC/WACCN/A
WACC9.5%
2.3 Liquidity
- A Current Ratio of 17.70 indicates that FULC has no problem at all paying its short term obligations.
- The Current ratio of FULC (17.70) is better than 87.96% of its industry peers.
- A Quick Ratio of 17.70 indicates that FULC has no problem at all paying its short term obligations.
- FULC has a Quick ratio of 17.70. This is amongst the best in the industry. FULC outperforms 87.96% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 17.7 | ||
| Quick Ratio | 17.7 |
3. Growth
3.1 Past
- The earnings per share for FULC have decreased strongly by -280.65% in the last year.
- Looking at the last year, FULC shows a very strong growth in Revenue. The Revenue has grown by 2752.05%.
- The Revenue has been growing by 61.03% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-280.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%11.43%
Revenue 1Y (TTM)2752.05%
Revenue growth 3Y61.03%
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- FULC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.49% yearly.
- FULC is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.70% yearly.
EPS Next Y-446.25%
EPS Next 2Y-138.36%
EPS Next 3Y-86.76%
EPS Next 5Y27.49%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y12.7%
3.3 Evolution
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- FULC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year FULC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- FULC's earnings are expected to decrease with -86.76% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-138.36%
EPS Next 3Y-86.76%
5. Dividend
5.1 Amount
- FULC does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
FULCRUM THERAPEUTICS INC / FULC FAQ
What is the fundamental rating for FULC stock?
ChartMill assigns a fundamental rating of 4 / 10 to FULC.
What is the valuation status of FULCRUM THERAPEUTICS INC (FULC) stock?
ChartMill assigns a valuation rating of 0 / 10 to FULCRUM THERAPEUTICS INC (FULC). This can be considered as Overvalued.
Can you provide the profitability details for FULCRUM THERAPEUTICS INC?
FULCRUM THERAPEUTICS INC (FULC) has a profitability rating of 1 / 10.
How financially healthy is FULCRUM THERAPEUTICS INC?
The financial health rating of FULCRUM THERAPEUTICS INC (FULC) is 9 / 10.
Can you provide the expected EPS growth for FULC stock?
The Earnings per Share (EPS) of FULCRUM THERAPEUTICS INC (FULC) is expected to decline by -446.25% in the next year.